Variant Bio recently announced a multimillion-dollar deal with a pharmaceutical company, and some of that money will go to ...

Valerio Therapeutics is ending all clinical trials, including an ongoing phase 1/2 study for its investigational “DNA decoy” ...

Ginkgo Bioworks (DNA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings ...

Researchers at the University of Toronto have invented a new method that uses DNA sequencing to measure metabolites. This ...

The boundaries of computer technology are being redefined as biology merges with electronics. At the forefront of this ...

The criminal investigation tool is said to offer the potential to predict an individual's physical appearance based solely on ...

While some of the initial zeal around localized vaccine production in Africa has waned since the height of the COVID-19 pandemic, efforts to bolster the continent’s immunization autonomy—especially | ...

Applied DNA Sciences (NASDAQ:APDN – Get Free Report) is expected to issue its quarterly earnings data before the market opens ...

Advance quantum information systems through innovative material design. Develop ultrasensitive biosensors for non-invasive ...

Pacific Biosciences has moved into its new headquarters at 1305 O'Brien Drive in the Menlo Park Labs office complex in Menlo ...

Research in genetics and biotechnology has advanced by leaps and bounds in recent years, offering new hope for the treatment ...